1. Dr. Giuseppe Curigliano. Breast cancer therapy expert. Biography. 0
Dr. Giuseppe Curigliano, MD, explains the latest advances in treating HER2-positive, HER2-negative, and triple-negative breast cancer. He details the role of immunotherapy and the challenges...
▶⏸
2. Targeted therapy for breast cancer. What are the molecular targets of drugs? 1
Dr. Giuseppe Curigliano, MD, explains how targeted therapies are revolutionizing breast cancer treatment by attacking specific molecular targets. He details the latest breakthroughs in CDK4/6...
▶⏸
3. Precision medicine in breast cancer therapy. Targeted drugs or chemotherapy? 2
Dr. Giuseppe Curigliano, MD, explains how new targeted therapies and genomic tests are transforming early-stage treatment. He details the significant survival benefits of adding immunotherapy...
▶⏸
4. Hormone-positive, HER2-negative breast cancer. Antibody-drug conjugates. 3
Dr. Giuseppe Curigliano, MD, explains the latest advances in treating hormone receptor-positive, HER2-negative breast cancer. He details the use of PI3K alpha inhibitors like alpelisib...
▶⏸
5. HER2-positive breast cancer therapy. Tucatinib. Trastuzumab deruxtecan. 4
Dr. Giuseppe Curigliano, MD, explains the latest advancements in treating this aggressive breast cancer subtype. He details the significant role of new agents like the...
▶⏸
6. Triple-negative breast cancer therapy. Neoadjuvant therapy indications. 5
Dr. Giuseppe Curigliano, MD, explains the latest treatment advances for triple-negative breast cancer, including immunotherapy, antibody-drug conjugates, and PARP inhibitors. He details the critical role...
▶⏸
7. Breast cancer immunotherapy. Triple-negative breast cancer. Antibody-drug conjugates. 6
Dr. Giuseppe Curigliano, MD, explains how patient selection based on the tumor's immunological profile is critical for success. He details the significant benefits of using...
▶⏸
8. Immunotherapy side effects in breast cancer patients. 7
Dr. Giuseppe Curigliano, MD, explains the most common side effects of immune checkpoint inhibitors, including cutaneous rash, hepatitis, and colitis. He details how these autoimmune...
▶⏸
9. Future in breast cancer therapy. Deescalation of treatment. Cure of metastatic cancer? 8
Dr. Giuseppe Curigliano, MD, explains the future of treatment, focusing on three key concepts: de-escalation of therapy for low-risk patients, development of better-tolerated medications to...
▶⏸
10. Metastatic triple-negative breast cancer. Long-term survival. Clinical case. 9
Dr. Giuseppe Curigliano, MD, explains how a patient with metastatic triple-negative breast cancer achieved long-term survival for nearly a decade after treatment with a combination...
▶⏸
11. ‘You must give the patient a human touch.’ Top breast cancer expert shares wisdom. 10
Dr. Giuseppe Curigliano, MD, explains the critical importance of the human touch in patient care, emphasizing that compassion and personal attention are as vital as...
▶⏸
12. test vimeo embed
Refine your treatment plan with a panel of top doctors who precisely fit your case.
